Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness.
Shaver N, Katz M, Darko Asamoah G, Linkins LA, Abdelkader W, Beck A, Bennett A, Hughes SE, Smith M, Begin M, Coyle D, Piggott T, Kagina BM, Welch V, Colijn C, Earn DJD, El Emam K, Heffernan J, O'Brien SF, Wilson K, Collins E, Navarro T, Beyene J, Boutron I, Bowdish D, Cooper C, Costa A, Curran J, Griffith L, Hsu A, Grimshaw J, Langlois MA, Li X, Pham-Huy A, Raina P, Rubini M, Thabane L, Wang H, Xu L, Brouwers M, Horsley T, Lavis J, Iorio A, Little J. Shaver N, et al. Among authors: langlois ma. Vaccine. 2023 Oct 13;41(43):6411-6418. doi: 10.1016/j.vaccine.2023.09.012. Epub 2023 Sep 16. Vaccine. 2023. PMID: 37718186 Free article. Review.
Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination.
Keeshan A, Galipeau Y, Heiskanen A, Collins E, McCluskie PS, Arnold C, Saginur R, Booth R, Little J, McGuinty M, Buchan CA, Crawley A, Langlois MA, Cooper C. Keeshan A, et al. Among authors: langlois ma. BMJ Open. 2023 Oct 31;13(10):e077714. doi: 10.1136/bmjopen-2023-077714. BMJ Open. 2023. PMID: 37907304 Free PMC article.
Serological markers and long COVID-A rapid systematic review.
Collins E, Philippe E, Gravel CA, Hawken S, Langlois MA, Little J. Collins E, et al. Among authors: langlois ma. Eur J Clin Invest. 2024 Apr;54(4):e14149. doi: 10.1111/eci.14149. Epub 2023 Dec 11. Eur J Clin Invest. 2024. PMID: 38083997 Review.
Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study.
Collins E, Galipeau Y, Arnold C, Bhéreur A, Booth R, Buchan AC, Cooper C, Crawley AM, McCluskie PS, McGuinty M, Pelchat M, Rocheleau L, Saginur R, Gravel C, Hawken S, Langlois MA, Little J. Collins E, et al. Among authors: langlois ma. Front Public Health. 2024 May 9;12:1276391. doi: 10.3389/fpubh.2024.1276391. eCollection 2024. Front Public Health. 2024. PMID: 38784593 Free PMC article.
COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies.
Bhella S, Wilkin AM, Hueniken K, Vijenthira A, Sebag M, Wang P, Hicks LK, Hay AE, Assouline S, Fraser G, Balitsky A, Mangel J, Owen C, Reiman A, Sehn L, Sutherland H, Zhang T, Arnold C, Leite T, McCarthy E, Cooper C, Langlois MA, Arianne Buchan C; VIP Study Investigators. Bhella S, et al. Among authors: langlois ma. Vaccine. 2024 Oct 24;42(24):126074. doi: 10.1016/j.vaccine.2024.06.041. Epub 2024 Jun 28. Vaccine. 2024. PMID: 38944577 Free article.
Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves.
Chambers C, Cooper CL, Kroch AE, Buchan SA, Kendall CE, Kwong JC, Moideddin R, Nguyen L, Arbess G, Benoit AC, Costiniuk CT, Habanyama M, Janjua NZ, Langlois MA, McCullagh J, Mbuagbaw L, Moqueet N, Nambiar D, Rueda S, Samji H, Tran V, Walmsley S, Anis A, Burchell AN; for the COVAXHIV Study Team. Chambers C, et al. Among authors: langlois ma. AIDS. 2024 Aug 1;38(10):1597-1600. doi: 10.1097/QAD.0000000000003922. Epub 2024 Jul 11. AIDS. 2024. PMID: 39422634 Free PMC article.
COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series.
Colmegna I, Valerio V, Amiable N, Useche M, Rampakakis E, Flamand L, Rollet-Labelle E, Bessette L, Fitzcharles MA, Hazel E, McCormack D, Michou L, Panopalis P, Langlois MA, Bernatsky S, Fortin PR. Colmegna I, et al. Among authors: langlois ma. RMD Open. 2023 Nov 29;9(4):e003400. doi: 10.1136/rmdopen-2023-003400. RMD Open. 2023. PMID: 38030231 Free PMC article. Clinical Trial.
Cohort profile: investigating SARS-CoV-2 infection and the health and psychosocial impact of the COVID-19 pandemic in the Canadian CHILD Cohort.
Azeez R, Lotoski L, Dubeau A, Rodriguez N, Reyna ME, Freitas T, Goguen S, Medeleanu M, Winsor GL, Brinkman FSL, Cameron EE, Roos L, Simons E, Moraes TJ, Mandhane PJ, Turvey SE, Bolotin S, Wright K, McNeil D, Patrick DM, Bullard J, Langlois MA, Arnold CR, Galipeau Y, Pelchat M, Doucas N, Subbarao P, Azad MB. Azeez R, et al. Among authors: langlois ma. Epidemiol Health. 2023;45:e2023091. doi: 10.4178/epih.e2023091. Epub 2023 Oct 13. Epidemiol Health. 2023. PMID: 37857338 Free PMC article.
The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study.
Almeida ND, Schiller I, Ke D, Sakr E, Plesa M, Vanamala S, Moneger AL, Bazan M, Lucchesi C, Wozniak N, Fritz JH, Piccirillo CA, Pelchat M, Arnold C, Galipeau Y, McCluskie PS, Langlois MA, Dasgupta K, Mazer BD. Almeida ND, et al. Among authors: langlois ma. Front Immunol. 2024 Feb 16;15:1330549. doi: 10.3389/fimmu.2024.1330549. eCollection 2024. Front Immunol. 2024. PMID: 38433831 Free PMC article.
96 results